首页> 外文OA文献 >RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale

【2h】

RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale

机译：研究（Statin和ezetimibe疗法对实现LDL-C目标的公认作用），一项以医生为中心的随机，多中心试验，比较了大剂量他汀类药物与ezetimibe加他汀类药物对日本人血清LDL-C浓度的影响2型糖尿病患者的设计和基本原理

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese [J] . Takeshi Inazawa, Kentaro Sakamoto, Takahide Kohro, Lipids in Health Disease . 2013,第3期

机译：研究（Statin和ezetimibe疗法对实现LDL-C目标的公认作用），一项以医生为中心的随机，多中心试验，比较高剂量他汀类药物与ezetimibe加他汀类药物对日本人血清LDL-C浓度的影响
2. Effectiveness and Safety of Ezetimibe Added to Statin Therapy in Patients with Primary Dyslipidaemia not Achieving the LDL-C Treatment Goal on Statin Monotherapy [J] . Carlos A. Gonzalez, Alberto F. Rubio-Guerra, Abel Pavia, Clinical drug investigation . 2007,第5期

机译：在依他汀单药治疗中未达到LDL-C治疗目标的原发性血脂异常患者中，依他替米贝联合他汀治疗的有效性和安全性
3. Superior benefit of aggressive lipid-lowering therapy for high- risk patients using statins: the SUBARU study--more hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin therapy. [J] . Kurabayashi M, Yamazaki T Journal of atherosclerosis and thrombosis. . 2008,第6期

机译：SUBARU研究表明，积极的降脂疗法对使用他汀类药物的高危患者的优越性：SUBBARU研究表明，与舒马汀相比，使用瑞舒伐他汀治疗的高胆固醇血症患者达到日本动脉粥样硬化学会LDL-C的目标。
4. RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal) a randomized doctor-oriented multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale [O] . Takeshi Inazawa, Kentaro Sakamoto, Takahide Kohro, 2013

机译：研究（Statin和ezetimibe疗法对实现LDL-C目标的公认作用）一项以医生为中心的随机多中心试验比较了大剂量他汀类药物与ezetimibe加他汀类药物对日本人血清LDL-C浓度的影响2型糖尿病患者的设计和基本原理
5. Superior Benefit of Aggressive Lipid-Lowering Therapy for High- Risk Patients Using Statins: the SUBARU Study -More Hypercholesterolemic Patients Achieve Japan Atherosclerosis Society LDL-C Goals with Rosuvastatin Therapy than with Atorvastatin Therapy [O] . Masahiko Kurabayashi, Tsutomu Yamazaki 2008

机译：使用他汀类药物对高风险患者进行侵略性脂质降低治疗的优越益处：亚马鲁学习 - 莫尔过热症患者实现日本动脉粥样硬化协会LDL-C与罗斯汀治疗的目标比阿托伐他汀治疗

著录项

相似文献

相关主题

期刊订阅